Your browser doesn't support javascript.
loading
SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance.
Fazio, Maurizio; van Rooijen, Ellen; Dang, Michelle; van de Hoek, Glenn; Ablain, Julien; Mito, Jeffrey K; Yang, Song; Thomas, Andrew; Michael, Jonathan; Fabo, Tania; Modhurima, Rodsy; Pessina, Patrizia; Kaufman, Charles K; Zhou, Yi; White, Richard M; Zon, Leonard I.
Afiliación
  • Fazio M; Howard Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.
  • van Rooijen E; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, United States.
  • Dang M; Howard Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.
  • van de Hoek G; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, United States.
  • Ablain J; Howard Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.
  • Mito JK; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, United States.
  • Yang S; Howard Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.
  • Thomas A; Howard Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.
  • Michael J; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, United States.
  • Fabo T; Howard Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.
  • Modhurima R; Brigham and Women's Hospital, Department of Pathology, Boston, United States.
  • Pessina P; Howard Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.
  • Kaufman CK; Howard Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.
  • Zhou Y; Howard Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.
  • White RM; Howard Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States.
  • Zon LI; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, United States.
Elife ; 102021 02 02.
Article en En | MEDLINE | ID: mdl-33527896

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Resistencia a Antineoplásicos / Proteínas de Pez Cebra / Proteínas de Unión a la Región de Fijación a la Matriz / Melanoma / Invasividad Neoplásica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Elife Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factores de Transcripción / Resistencia a Antineoplásicos / Proteínas de Pez Cebra / Proteínas de Unión a la Región de Fijación a la Matriz / Melanoma / Invasividad Neoplásica Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Elife Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido